Skip to main content
. Author manuscript; available in PMC: 2017 Jun 1.
Published in final edited form as: Ann Allergy Asthma Immunol. 2016 May 4;116(6):544–553. doi: 10.1016/j.anai.2016.03.030

Figure 3.

Figure 3

Figure 3

Immune-mediated Hypersensitivity Reactions to Vancomycin. (a) Timing of Hypersensitivity Reactions (b) Observed fatalities by Hypersensitivity Reaction

Legend: (A) Median time to onset of hypersensitivity reactions varied by type. (B) Overall 11 (16%) of patients with vancomycin HSRs died, with 4(6%) of deaths attributed to HSR.